285 related articles for article (PubMed ID: 31710321)
21. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1, Id1 and EMT in breast cancer.
Tobin NP; Sims AH; Lundgren KL; Lehn S; Landberg G
BMC Cancer; 2011 Sep; 11():417. PubMed ID: 21955753
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.
Salnikov AV; Liu L; Platen M; Gladkich J; Salnikova O; Ryschich E; Mattern J; Moldenhauer G; Werner J; Schemmer P; Büchler MW; Herr I
PLoS One; 2012; 7(9):e46391. PubMed ID: 23050024
[TBL] [Abstract][Full Text] [Related]
24. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal-mode migration assay and antimetastatic drug screening with high-throughput microfluidic channel networks.
Zhang Y; Zhang W; Qin L
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2344-8. PubMed ID: 24478127
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
[TBL] [Abstract][Full Text] [Related]
27. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
28. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.
Rahimi M; Sharifi-Zarchi A; Firouzi J; Azimi M; Zarghami N; Alizadeh E; Ebrahimi M
J Cell Mol Med; 2019 Apr; 23(4):2442-2456. PubMed ID: 30710426
[TBL] [Abstract][Full Text] [Related]
29. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
[TBL] [Abstract][Full Text] [Related]
30. Morphology-based prediction of cancer cell migration using an artificial neural network and a random decision forest.
Zhang Z; Chen L; Humphries B; Brien R; Wicha MS; Luker KE; Luker GD; Chen YC; Yoon E
Integr Biol (Camb); 2018 Dec; 10(12):758-767. PubMed ID: 30420987
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma.
Song J; Wang W; Wang Y; Qin Y; Wang Y; Zhou J; Wang X; Zhang Y; Wang Q
BMC Cancer; 2019 Jul; 19(1):680. PubMed ID: 31296175
[TBL] [Abstract][Full Text] [Related]
32. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of XB130 restrains cancer stem cell-like phenotype through inhibition of Wnt/β-Catenin signaling in breast cancer.
Xie T; Jiang C; Dai T; Xu R; Zhou X; Su X; Zhao X
Mol Carcinog; 2019 Oct; 58(10):1832-1845. PubMed ID: 31219645
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
35. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
36. Improving single-cell transcriptome sequencing efficiency with a microfluidic phase-switch device.
Zhang B; Xu H; Huang Y; Shu W; Feng H; Cai J; Zhong JF; Chen Y
Analyst; 2019 Dec; 144(24):7185-7191. PubMed ID: 31688860
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer.
Ionkina AA; Balderrama-Gutierrez G; Ibanez KJ; Phan SHD; Cortez AN; Mortazavi A; Prescher JA
Breast Cancer Res; 2021 Sep; 23(1):93. PubMed ID: 34579762
[TBL] [Abstract][Full Text] [Related]
38. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
40. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]